Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and...
Inotuzumab ozogamicin (InO) is an antibody-drug conjugate approved for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (ALL). Several clinical trials are investigating InO in...
pubmed.ncbi.nlm.nih.gov